1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Kimberly Lyman conducted an unannounced visit for the purpose of initiating an investigation on the above allegations. LPA was greeted and granted entry into the facility and explained the reason for the visit.
During the course of the investigation, LPA toured the facility, interviewed staff and witnesses as well as reviewed and obtained pertinent documentation such as medication orders and medication administration record. R1 was prescribed Lorazepam 2MG (Ativan) as needed (PRN). Per medication administration record, R1 was given Lorazepam once on January 3, 2023 and four times in December. Lorazepam was discontinued on January 11, 2023. Resident did not receive the medication after the stop date nor on the date of R1's hospital send out, January 8, 2023. Therefore the allegation is deemed UNFOUNDED, meaning the allegation was false, could not have happened and/or is without a reasonable basis. Exit interview conducted and a copy of this report was left at the facility. |